Patient Care Research Group
This initiative began in 2008 to help integrate psychosocial research into the work of the Department of Women’s Cancer. Close collaboration between Anne and her Consultant Clinical Psychologist colleague Dr. Sue Gessler has established a programme of work with a team of doctoral and post doctoral research fellows. We conduct research that is women centred, clinically applied and relevant to the diversity of women’s lives across the life span.
Patient care research investigates the experiences of individuals in health and illness, with emphasis on health related quality of life and the role of care -givers – self, family, and professionals – in health promotion, psychological response and disease management. We are committed to develop a research programme which challenges routinised accounts of women’s health and tests new ways of working with women. The purpose of this is on the one hand, to equip women to more actively manage their own health and meet the challenges posed by their cancer, and on the other, to contribute to an understanding of how health professionals can work to support this, while offering first class clinical care.
Our overall aim is to develop novel strategies for improved health outcomes in psychological response and in the prevention and palliation of disease and treatment related symptoms in women’s cancer. Specific areas of work are:
Quality of life in women’s cancer
Quality of life instruments.
Developing quality of life measures for use in large clinical trials. These measures are needed to understand the quality-of-life benefits and risks of different treatments so women can weigh up the balance of benefit and harm and make informed treatment choices. Instruments currently under development with The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Group: Sexual health; fatigue; and vulva cancer.
Symptoms in women’s cancer
Symptom benefit study.
Investigating quality of life issues related to ovarian cancer and chemotherapy. We are interested in finding out how women do during chemotherapy and whether symptom improvement occurs with treatment. We will also develop better ways to predict which women may be most likely to benefit from chemotherapy.
Nutritional status and nutritional interventions in ovarian cancer.
Describing the nutritional status of women newly diagnosed with ovarian cancer and develop effective nutritional interventions. Our work in this area takes account of the complex relation of nutrition with gastrointestinal symptom logy in ovarian cancer.
Gastrointestinal symptoms in ovarian cancer.
Optimising women’s self-management of gastro intestinal symptoms in ovarian cancer, we will first identify and provide detailed description of gastrointestinal symptoms and symptom clusters. Then we will refine assessment protocols, and treatment algorithms for improved prevention and relief of the symptoms.
Innovative psychological therapies, evaluation and implementation in the clinical setting
Psychosexual interventions after treatment for gynaecological cancer.
Developing and evaluating in a feasibility trial an integrated approach to psychosexual difficulties after treatment.
Understanding the psychological mechanisms in peer support between new and post treatment gynaecological cancer patients
Virtual heritage-object therapy.
Developing and testing virtual heritage-object applications for management of cancer related stress.
PROMISE 2016 - Risk stratification, early detection and diagnosis of ovarian cancer.
Evaluating the health behavioural aspects for ovarian cancer risk prediction and screening on a population wide basis.
Interventions to relieve distress and promote psychological wellbeing in advanced cancer.
Assessing the feasibility of training nurse specialists to deliver to a high standard a manualised therapy previously carried out only by psychologically trained personnel. This intervention widens and deepens the traditional role of the nurse specialist, drawing on attachment based therapies with close supervision to allow patients to work on areas where their relationships are changing in the face of advanced disease, and where distress and depression may interfere with the task of facing a shortened life with comfort, dignity and a sense of meaning.
We would be very pleased to hear from individuals wishing to join the team and undertake a PhD relevant to the above areas of research.
Dr. Anne Lanceley
Senior Lecturer in Women’s Cancer, Dept Women’ Cancer
Institute for Women’s Health
Honorary Clinical Nurse Specialist, UCLH Gynaecological Cancer Centre
Medical School Building
74, Huntley Street
London WC1E 6AU
Tel: 020 767 96807
Dr. Sue Gessler
Consultant Clinical Psychologist, UCLH Gynaecological Cancer Centre
Honorary Senior Lecturer, Department of Women’s Cancer, Institute for Women's Health
2nd Floor North
250 Euston Road
London NW1 2PG
Phone: 020 3447 8636
Page last modified on 12 nov 13 11:10